Skip to main content
. 2021 Jul 21;14:3687–3698. doi: 10.2147/IJGM.S316344

Table 5.

Correlation Between Epidermal Growth Factor Receptor 19 Deletion and L858R Mutation Status and CT Morphological Classification of Lung Adenocarcinoma

Characteristics Total (n = 566) 19del (+) (n = 230) Non-19del (+)(n = 336) P valuea L858R (+) (n = 265) Non-L858R (+) (n = 301) P valuea
Type I
 Yes 284 122/284 (42.96) 162/284 (57.04) 0.259 129/284 (45.42) 155/284 (54.58) 0.504
 No 282 108/282 (38.30) 174/282 (61.70) 136/282 (48.23) 146/282 (51.77)
Type II
 Yes 101 36/101 (35.64) 65/101 (64.36) 0.260 52/101 (51.49) 49/101 (48.51) 0.300
 No 465 194/465 (41.72) 271/465 (58.28) 213/465 (45.81) 252/465 (54.19)
Type III
 Yes 60 25/60 (41.67) 35/60 (58.33) 0.864 30/60 (50.00) 30/60 (50.00) 0.602
 No 506 205/506 (40.51) 301/506 (59.49) 235/506 (46.44) 271/506 (53.56)
Type IV
 Yes 25 10/25 (40.00) 15/25 (60.00) 0.947 12/25 (48.00) 13/25 (52.00) 0.904
 No 541 220/541 (40.67) 321/541 (59.33) 253/541 (46.77) 288/541 (53.23)
Type V
 Yes 8 1/8 (12.50) 7/8 (87.50) 0.204 6/8 (75.00) 2/8 (25.00) 0.207
 No 558 229/558 (41.04) 329/558 (58.96) 258/558 (46.24) 300/558 (53.76)
Type VI
 Yes 47 15/47 (31.91) 32/47 (68.09) 0.204 24/47 (51.06) 23/47 (48.94) 0.543
 No 519 215/519 (41.43) 304/519 (58.57) 241/519 (46.44) 278/519 (53.56)
Type VII
 Yes 19 14/19 (73.68) 5/19 (26.32) 0.003 4/19 (21.05) 15/19 (78.95) 0.022
 No 547 216/547 (38.94) 331/547 (60.51) 261/547 (47.71) 286/547 (52.29)
Type VIII
 Yes 22 7/22 (31.82) 15/22 (68.18) 0.390 7/22 (31.82) 15/22 (68.18) 0.150
 No 544 223/544 (40.99) 321/544 (59.01) 258/544 (47.43) 286/544 (52.57)

Notes: Data are presented as number/total (%). aChi-squared test.